Metabolic functions of FABPs - Mechanisms and therapeutic implications

Nature Reviews Endocrinology

Volumn 11, Issue 10, 2015, Pages 592-605

  Hotamisligil, Gökhan S ^a   Bernlohr, David A ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; FABP4 PROTEIN, HUMAN;

ADIPOCYTE; ADIPOSE TISSUE; CELL FUNCTION; CHRONIC DISEASE; GENE EXPRESSION; HUMAN; IMMUNITY; INFLAMMATION; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SECRETION; REVIEW; ANIMAL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; LIPID METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION; HUMANS; INFLAMMATION; LIPID METABOLISM; MICE;

EID: 84941876397     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2015.122     Document Type: Review

References (175)

1. Poveda J. A., et al. Lipid modulation of ion channels through specific binding sites. Biochim. Biophys. Acta 1838, 1560-1567 (2014
2. Wahli W., & Michalik L. PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol. Metab. 23, 351-363 (2012
3. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 49, 123-150 (2009
4. Dresner A., et al. Effects of free fatty acids on glucose transport and IRS 1 associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103, 253-259 (1999
5. Cho H., et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB β). Science 292, 1728-1731 (2001
6. Kim J. K., et al. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108, 437-446 (2001
7. Solinas G., Naugler W., Galimi F., Lee M. S., & Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl Acad. Sci. USA 103, 16454-16459 (2006
8. Nguyen M. T., et al. JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280, 35361-35371 (2005
9. Shi H., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025 (2006
10. Severeid L., Connor W. E., & Long J. P. The depressant effect of fatty acids on the isolated rabbit heart. Proc. Soc. Exp. Biol. Med. 131, 1239-1243 (1969
11. Gordon G. B. Saturated free fatty acid toxicity. II. Lipid accumulation, ultrastructural alterations, and toxicity in mammalian cells in culture. Exp. Mol. Pathol. 27, 262-276 (1977
12. Ockner R. K., Manning J. A., Poppenhausen R. B., & Ho W. K. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science 177, 56-58 (1972
13. Ockner R. K., & Manning J. A. Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport. J. Clin. Invest. 54, 326-338 (1974
14. Furuhashi M., & Hotamisligil G. S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 7, 489-503 (2008
15. Ockner R. K., & Manning J. A. Fatty acid binding protein. Role in esterification of absorbed long chain fatty acid in rat intestine. J. Clin. Invest. 58, 632-641 (1976
16. Li L. O., Klett E. L., & Coleman R. A. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. Biochim. Biophys. Acta 1801, 246-251 (2010
17. Ockner R. K., Manning J. A., & Kane J. P. Fatty acid binding protein. Isolation from rat liver, characterization, and immunochemical quantification. J. Biol. Chem. 257, 7872-7878 (1982
18. Gordon J. I., Alpers D. H., Ockner R. K., & Strauss A. W. The nucleotide sequence of rat liver fatty acid binding protein mRNA. J. Biol. Chem. 258, 3356-3363 (1983
19. Bass N. M., Raghupathy E., Rhoads D. E., Manning J. A., & Ockner R. K. Partial purification of molecular weight 12,000 fatty acid binding proteins from rat brain and their effect on synaptosomal Na+-dependent amino acid uptake. Biochemistry 23, 6539-6544 (1984
20. Haq R. U., Shrago E., Christodoulides L., & Ketterer B. Purification and characterization of fatty acid binding protein in mammalian lung. Exp. Lung Res. 9, 43-55 (1985
21. Sweetser D. A., Lowe J. B., & Gordon J. I. The nucleotide sequence of the rat liver fatty acid-binding protein gene. Evidence that exon 1 encodes an oligopeptide domain shared by a family of proteins which bind hydrophobic ligands. J. Biol. Chem. 261, 5553-5561 (1986
22. Sacchettini J. C., Said B., Schulz H., & Gordon J. I. Rat heart fatty acid-binding protein is highly homologous to the murine adipocyte 422 protein and the P2 protein of peripheral nerve myelin. J. Biol. Chem. 261, 8218-8223 (1986
23. Madsen P., Rasmussen H. H., Leffers H., Honore B., & Celis J. E. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol. 99, 299-305 (1992
24. Kurtz A., et al. The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development 120, 2637-2649 (1994
25. Watanabe R., et al. Molecular cloning of a cDNA encoding a novel fatty acid-binding protein from rat skin. Biochem. Biophys. Res. Commun. 200, 253-259 (1994
26. Spiegelman B. M., & Green H. Control of specific protein biosynthesis during the adipose conversion of 3T3 cells. J. Biol. Chem. 255, 8811-8818 (1980
27. Bernlohr D. A., Angus C. W., Lane M. D., Bolanowski M. A., & Kelly T. J. Jr. Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc. Natl Acad. Sci. USA 81, 5468-5472 (1984
28. Haq R. U., Christodoulides L., Ketterer B., & Shrago E. Characterization and purification of fatty acid-binding protein in rat and human adipose tissue. Biochim. Biophys. Acta 713, 193-198 (1982
29. LaLonde J. M., Bernlohr D. A., & Banaszak L. J. The up and down β-barrel proteins. FASEB J. 8, 1240-1247 (1994
30. Storch J., & Thumser A. E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 285, 32679-32683 (2010
31. Zezulak K. M., & Green H. Specificity of gene expression in adipocytes. Mol. Cell Biol. 5, 419-421 (1985
32. Bernlohr D. A., Doering T. L., Kelly T. J. Jr, & Lane M. D. Tissue specific expression of p422 protein, a putative lipid carrier, in mouse adipocytes. Biochem. Biophys. Res. Commun. 132, 850-855 (1985
33. Matarese V., & Bernlohr D. A. Purification of murine adipocyte lipid-binding protein. Characterization as a fatty acid- and retinoic acid-binding protein. J. Biol. Chem. 263, 14544-14551 (1988
34. Blake W. L., & Clarke S. D. Induction of adipose fatty acid binding protein (a-FABP) by insulin-like growth factor-1 (IGF-1) in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 173, 87-91 (1990
35. Amri E. Z., Ailhaud G., & Grimaldi P. Regulation of adipose cell differentiation. II. Kinetics of induction of the aP2 gene by fatty acids and modulation by dexamethasone. J. Lipid Res. 32, 1457-1463 (1991
36. Amri E. Z., Bertrand B., Ailhaud G., & Grimaldi P. Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J. Lipid Res. 32, 1449-1456 (1991
37. Distel R. J., Robinson G. S., & Spiegelman B. M. Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms. J. Biol. Chem. 267, 5937-5941 (1992
38. Tontonoz P., Hu E., & Spiegelman B. M. Stimulation of adipogenesis in fibroblasts by PPARγ 2, a lipid-activated transcription factor. Cell 79, 1147-1156 (1994
39. Pelton P. D., Zhou L., Demarest K. T., & Burris T. P. PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem. Biophys. Res. Commun. 261, 456-458 (1999
40. Shum B. O., et al. The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J. Clin. Invest. 116, 2183-2192 (2006
41. Wootan M. G., Bass N. M., Bernlohr D. A., & Storch J. Fatty acid binding sites of rodent adipocyte and heart fatty acid binding proteins: characterization using fluorescent fatty acids. Biochemistry 29, 9305-9311 (1990
42. Xu Z., Bernlohr D. A., & Banaszak L. J. The adipocyte lipid-binding protein at 1.6-A resolution. Crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids. J. Biol. Chem. 268, 7874-7884 (1993
43. Richieri G. V., Ogata R. T., & Kleinfeld A. M. Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J. Biol. Chem. 269, 23918-23930 (1994
44. Wootan M. G., Bernlohr D. A., & Storch J. Mechanism of fluorescent fatty acid transfer from adipocyte fatty acid binding protein to membranes. Biochemistry 32, 8622-8627 (1993
45. Gericke A., Smith E. R., Moore D. J., Mendelsohn R., & Storch J. Adipocyte fatty acid-binding protein: interaction with phospholipid membranes and thermal stability studied by FTIR spectroscopy. Biochemistry 36, 8311-8317 (1997
46. Herr F. M., Matarese V., Bernlohr D. A., & Storch J. Surface lysine residues modulate the collisional transfer of fatty acid from adipocyte fatty acid binding protein to membranes. Biochemistry 34, 11840-11845 (1995
47. LiCata V. J., & Bernlohr D. A. Surface properties of adipocyte lipid-binding protein: response to lipid binding, and comparison with homologous proteins. Proteins 33, 577-589 (1998
48. Banaszak L., et al. Lipid-binding proteins: a family of fatty acid and retinoid transport proteins. Adv. Protein Chem. 45, 89-151 (1994
49. Jenkins-Kruchten A. E., et al. Fatty acid-binding protein hormone sensitive lipase interaction. Fatty acid dependence on binding. J. Biol. Chem. 278, 47636-47643 (2003
50. Hellberg K., et al. X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4 hydroxy 2-nonenal. Protein Sci. 19, 1480-1489 (2010
51. Borchers T., & Spener F. Involvement of arginine in the binding of heme and fatty acids to fatty acid-binding protein from bovine liver. Mol. Cell Biochem. 123, 23-27 (1993
52. Jenkins A. E., Hockenberry J. A., Nguyen T., & Bernlohr D. A. Testing of the portal hypothesis: analysis of a V32G, F57G, K58G mutant of the fatty acid binding protein of the murine adipocyte. Biochemistry 41, 2022-2027 (2002
53. Sha R. S., Kane C. D., Xu Z., Banaszak L. J., & Bernlohr D. A. Modulation of ligand binding affinity of the adipocyte lipid-binding protein by selective mutation. Analysis in vitro and in situ. J. Biol. Chem. 268, 7885-7892 (1993
54. Grimsrud P. A., Picklo M. J. Sr, Griffin T. J., & Bernlohr D. A. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell Proteomics 6, 624-637 (2007
55. Chabowski A., Gorski J., Luiken J. J., Glatz J. F., & Bonen A. Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot. Essent. Fatty Acids 77, 345-353 (2007
56. Glatz J. F., Luiken J. J., & Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 90, 367-417 (2010
57. Spitsberg V. L., Matitashvili E., & Gorewit R. C. Association and coexpression of fatty acid binding protein and glycoprotein CD36 in the bovine mammary gland. Eur. J. Biochem. 230, 872-878 (1995
58. Woodford J. K., Jefferson J. R., Wood W. G., Hubbell T., & Schroeder F. Expression of liver fatty acid binding protein alters plasma membrane lipid composition and structure in transfected L-cell fibroblasts. Biochim. Biophys. Acta 1145, 257-265 (1993
59. Iso T., et al. Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle. Arterioscler. Thromb. Vasc. Biol. 33, 2549-2557 (2013
60. Murphy E. J., Prows D. R., Stiles T., & Schroeder F. Liver and intestinal fatty acid-binding protein expression increases phospholipid content and alters phospholipid fatty acid composition in L-cell fibroblasts. Lipids 35, 729-738 (2000
61. Maeda K., et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 1, 107-119 (2005
62. Coe N. R., Simpson M. A., & Bernlohr D. A. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J. Lipid Res. 40, 967-972 (1999
63. Shaughnessy S., Smith E. R., Kodukula S., Storch J., & Fried S. K. Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. Diabetes 49, 904-911 (2000
64. Scheja L., et al. Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes 48, 1987-1994 (1999
65. Hertzel A. V., et al. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am. J. Physiol. Endocrinol. Metab. 290, E814-E823 (2006
66. Storch J., & Thumser A. E. The fatty acid transport function of fatty acid-binding proteins. Biochim. Biophys. Acta 1486, 28-44 (2000
67. Schroeder F., et al. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 43, 1-17 (2008
68. Huang H., Starodub O., McIntosh A., Kier A. B., & Schroeder F. Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J. Biol. Chem. 277, 29139-29151 (2002
69. Yu S., Levi L., Siegel R., & Noy N. Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor β/δ (PPARβ/δ). J. Biol. Chem. 287, 42195-42205 (2012
70. Yu S., Levi L., Casadesus G., Kunos G., & Noy N. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain. J. Biol. Chem. 289, 12748-12758 (2014
71. Tan N. S., et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol. Cell Biol. 22, 5114-5127 (2002
72. Adida A., & Spener F. Adipocyte-type fatty acid-binding protein as inter-compartmental shuttle for peroxisome proliferator activated receptor γ agonists in cultured cell. Biochim. Biophys. Acta 1761, 172-181 (2006
73. Ayers S. D., Nedrow K. L., Gillilan R. E., & Noy N. Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARγ by FABP4. Biochemistry 46, 6744-6752 (2007
74. Makowski L., Brittingham K. C., Reynolds J. M., Suttles J., & Hotamisligil G. S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities. J. Biol. Chem. 280, 12888-12895 (2005
75. Hotamisligil G. S., et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274, 1377-1379 (1996
76. Bernlohr D. A., Coe N. R., Simpson M. A., & Hertzel A. V. Regulation of gene expression in adipose cells by polyunsaturated fatty acids. Adv. Exp. Med. Biol. 422, 145-156 (1997
77. Uysal K. T., Scheja L., Wiesbrock S. M., Bonner-Weir S., & Hotamisligil G. S. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141, 3388-3396 (2000
78. Maeda K., et al. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52, 300-307 (2003
79. Cao H., et al. Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice. Diabetes 55, 1915-1922 (2006
80. Cao H., et al. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134, 933-944 (2008
81. Erbay E., et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat. Med. 15, 1383-1391 (2009
82. Oh D. Y., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698 (2010
83. Ichimura A., et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350-354 (2012
84. Shen W. J., Sridhar K., Bernlohr D. A., & Kraemer F. B. Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein. Proc. Natl Acad. Sci. USA 96, 5528-5532 (1999
85. Smith A. J., et al. Physical association between the adipocyte fatty acid-binding protein and hormone-sensitive lipase: a fluorescence resonance energy transfer analysis. J. Biol. Chem. 279, 52399-52405 (2004
86. Hampton M., et al. Deep sequencing the transcriptome reveals seasonal adaptive mechanisms in a hibernating mammal. PLoS ONE 6, e27021 (2011
87. Tontonoz P., Nagy L., Alvarez J. G., Thomazy V. A., & Evans R. M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252 (1998
88. Fu Y., Luo N., Lopes-Virella M. F., & Garvey W. T. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 165, 259-269 (2002
89. Liu Q. Y., & Nambi P. Sirolimus upregulates aP2 expression in human monocytes and macrophages. Transplant Proc. 36, 3229-3231 (2004
90. Liu Q. Y., Quinet E., & Nambi P. Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells. Mol. Cell Biochem. 302, 203-213 (2007
91. Babaev V. R., et al. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor γ regulated genes. Arterioscler. Thromb. Vasc. Biol. 31, 1283-1290 (2011
92. Garin-Shkolnik T., Rudich A., Hotamisligil G. S., & Rubinstein M. FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues. Diabetes 63, 900-911 (2014
93. Zimmer J. S., Dyckes D. F., Bernlohr D. A., & Murphy R. C. Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products. J. Lipid Res. 45, 2138-2144 (2004
94. Dickinson Zimmer J. S., Voelker D. R., Bernlohr D. A., & Murphy R. C. Stabilization of leukotriene A4 by epithelial fatty acid-binding protein in the rat basophilic leukemia cell. J. Biol. Chem. 279, 7420-7426 (2004
95. Spite M., et al. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity. J. Immunol. 187, 1942-1949 (2011
96. Layne M. D., et al. Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J. 15, 2733-2735 (2001
97. Chan K. L., et al. Palmitoleate reverses high fat-induced pro-inflammatory macrophage polarization via AMPK. J. Biol. Chem. http://dx.doi.org/10.1074/jbc.M115.646992
98. Xu H., et al. Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2. Mol. Cell Biol. 35, 1055-1065 (2015
99. Thompson B. R., Mazurkiewicz-Munoz A. M., Suttles J., Carter-Su C., & Bernlohr D. A. Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling. J. Biol. Chem. 284, 13473-13480 (2009
100. Semenkovich C. F. Insulin resistance and atherosclerosis. J. Clin. Invest. 116, 1813-1822 (2006
101. Perrella M. A., et al. Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J. 15, 1774-1776 (2001
102. Makowski L., et al. Lack of macrophage fatty acid binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 7, 699-705 (2001
103. Boord J. B., et al. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 22, 1686-1691 (2002
104. Furuhashi M., et al. Treatment of diabetes and atherosclerosis by inhibiting fatty acid binding protein aP2. Nature 447, 959-965 (2007
105. Boord J. B., et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 110, 1492-1498 (2004
106. Rolph M. S., et al. Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2. J. Immunol. 177, 7794-7801 (2006
107. Reynolds J. M., et al. Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis. J. Immunol. 179, 313-321 (2007
108. Elmasri H., et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J. 23, 3865-3873 (2009
109. Harjes U., Bridges E., McIntyre A., Fielding B. A., & Harris A. L. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells. J. Biol. Chem. 289, 23168-23176 (2014
110. Daly C., et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 18, 1060-1071 (2004
111. Elmasri H., et al. Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway. Angiogenesis 15, 457-468 (2012
112. Ghelfi E., et al. Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. Am. J. Pathol. 182, 1425-1433 (2013
113. Saint-Geniez M., et al. Fatty acid binding protein 4 deficiency protects against oxygen-induced retinopathy in mice. PLoS ONE 9, e96253 (2014
114. Nieman K. M., et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498-1503 (2011
115. Cataltepe O., et al. Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma. Neuropathol. Appl. Neurobiol. 38, 400-410 (2012
116. Lee D., et al. Expression of fatty acid binding protein 4 is involved in the cell growth of oral squamous cell carcinoma. Oncol. Rep. 31, 1116-1120 (2014
117. Pelsers M. M., et al. Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin. Chem. 48, 2055-2057 (2002
118. Knowlton A. A., Apstein C. S., Saouf R., & Brecher P. Leakage of heart fatty acid binding protein with ischemia and reperfusion in the rat. J. Mol. Cell Cardiol. 21, 577-583 (1989
119. Tanaka T., Hirota Y., Sohmiya K., Nishimura S., & Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin. Biochem. 24, 195-201 (1991
120. Kleine A. H., Glatz J. F., Van Nieuwenhoven F. A., & Van der Vusse G. J. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol. Cell. Biochem. 116, 155-162 (1992
121. Kanda T., et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110, 339-343 (1996
122. Schellekens D. H., et al. Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J. Clin. Gastroenterol. 48, 253-260 (2014
123. Akbal E., et al. Liver fatty acid-binding protein is a diagnostic marker to detect liver injury due to chronic hepatitis C infection. Arch. Med. Res. 44, 34-38 (2013
124. Foucaud L., et al. Output of liver fatty acid-binding protein (L-FABP) in bile. Biochim. Biophys. Acta 1436, 593-599 (1999
125. Specht B., et al. Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocyte-type fatty acid-binding protein. J. Biol. Chem. 271, 19943-19949 (1996
126. Brandt R., et al. A 13-kilodalton protein purified from milk fat globule membranes is closely related to a mammary-derived growth inhibitor. Biochemistry 27, 1420-1425 (1988
127. Bronsky J., et al. Adiponectin, adipocyte fatty acid binding protein, and epidermal fatty acid binding protein: proteins newly identified in human breast milk. Clin. Chem. 52, 1763-1770 (2006
128. Cao H., et al. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab. 17, 768-778 (2013
129. Xu A., et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem. 52, 405-413 (2006
130. Schlottmann I., Ehrhart-Bornstein M., Wabitsch M., Bornstein S. R., & Lamounier-Zepter V. Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes. Int. J. Obes. (Lond.) 38, 1221-1227 (2014
131. Kaess B. M., et al. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J. Clin. Endocrinol. Metab. 97, E1943-E1947 (2012
132. Chow W. S., et al. Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study. J. Am. Heart Assoc. 2, e004176 (2013
133. von Eynatten M., et al. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler. Thromb. Vasc. Biol. 32, 2327-2335 (2012
134. Tso A. W., et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30, 2667-2672 (2007
135. Ishimura S., et al. Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS ONE 8, e81318 (2013
136. Tso A. W., et al. Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death. Neurology 76, 1968-1975 (2011
137. Balci M. M., et al. Serum levels of adipocyte fatty acid-binding protein are independently associated with left ventricular mass and myocardial performance index in obstructive sleep apnea syndrome. J. Investig. Med. 60, 1020-1026 (2012
138. Hancke K., Grubeck D., Hauser N., Kreienberg R., & Weiss J. M. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res. Treat. 119, 367-367 (2010
139. Yoo H. J., et al. Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography. J. Clin. Endocrinol. Metab. 96, E488-E492 (2011
140. Schmilovitz-Weiss H., et al. Serum adipocyte fatty acid binding protein in liver transplant recipients and the metabolic syndrome. Ann. Hepatol. 11, 343-349 (2012
141. Haluzikova D., et al. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol. Res. 58, 577-581 (2009
142. Comerford K. B., Buchan W., & Karakas S. E. The effects of weight loss on FABP4 and RBP4 in obese women with metabolic syndrome. Horm. Metab. Res. 46, 224-231 (2014
143. Stejskal D., Karpisek M., & Bronsky J. Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss. J. Clin. Lab. Anal. 22, 380-382 (2008
144. Tuncman G., et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc. Natl Acad. Sci. USA 103, 6970-6975 (2006
145. Saksi J., et al. Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability. Circ. Cardiovasc. Genet. 7, 588-598 (2014
146. Wang J., et al. FABP4: a novel candidate gene for polycystic ovary syndrome. Endocrine 36, 392-396 (2009
147. Bhushan B., et al. Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med. 12, 666-671 (2011
148. Unger R. H., & Cherrington A. D. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J. Clin. Invest. 122, 4-12 (2012
149. Wu L. E., et al. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity. Mol. Metab. 3, 465-473 (2014
150. Kralisch S., et al. Circulating adipocyte fatty acid-binding protein induces insulin resistance in mice in vivo. Obesity (Silver Spring) 23, 1007-1013 (2015
151. Girona J., et al. FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. PLoS ONE 8, e81914 (2013
152. Aragones G., et al. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc. Diabetol. 11, 72 (2012
153. Lamounier-Zepter V., et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ. Res. 105, 326-334 (2009
154. Lamounier-Zepter V., et al. Interaction of epoxyeicosatrienoic acids and adipocyte fatty acid-binding protein in the modulation of cardiomyocyte contractility. Int. J. Obes. (Lond.) 39, 755-761 (2015
155. Riquelme C. A., et al. Fatty acids identified in the Burmese python promote beneficial cardiac growth. Science 334, 528-531 (2011
156. Ertunc M. E., et al. Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity. J. Lipid Res. 56, 423-434 (2015
157. Sun K., Kusminski C. M., & Scherer P. E. Adipose tissue remodeling and obesity. J. Clin. Invest. 121, 2094-2101 (2011
158. Kralisch S., et al. Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism. Int. J. Obes. (Lond.) 38, 1251-1254 (2014
159. Lee M. Y., et al. Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells. Br. J. Pharmacol. 162, 1564-1576 (2011
160. Hoo R. L., et al. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. J. Hepatol. 58, 358-364 (2013
161. Lehmann F., et al. Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg. Med. Chem. Lett. 14, 4445-4448 (2004
162. Barf T., et al. N. Benzyl indolo carboxylic acids: design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Bioorg. Med. Chem. Lett. 19, 1745-1748 (2009
163. Liu X., et al. New aromatic substituted pyrazoles as selective inhibitors of human adipocyte fatty acid-binding protein. Bioorg. Med. Chem. Lett. 21, 2949-2952 (2011
164. Chen J., Wang J., & Zhu W. Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation. PLoS ONE 9, e99862 (2014
165. Xu Q., et al. Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes. Eur. J. Med. Chem. 52, 70-81 (2012
166. Wang Y., et al. Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening. J. Chem. Inf. Model 54, 3046-3050 (2014
167. Cai H. Y., et al. Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice. Acta Pharmacol. Sin. 34, 1397-1402 (2013
168. Aouadi M., et al. Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice. Proc. Natl Acad. Sci. USA 110, 8278-8283 (2013
169. Aouadi M., et al. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458, 1180-1184 (2009
170. Won Y. W., et al. Oligopeptide complex for targeted non-viral gene delivery to adipocytes. Nat. Mater. 13, 1157-1164 (2014
171. Miao X., et al. The mAb against adipocyte fatty acid-binding protein 2E4 attenuates the inflammation in the mouse model of high-fat diet-induced obesity via toll-like receptor 4 pathway. Mol. Cell. Endocrinol. 403, 1-9 (2015
172. Herroon M. K., et al. Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms. Oncotarget 4, 2108-2123 (2013
173. Yore M. M., et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 159, 318-332 (2014
174. Maceyka M., & Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature 510, 58-67 (2014
175. NCBI. Fabp4 [Mus musculus] GenBank: CAJ18597.1 [online], http://www.ncbi.nlm.nih.gov/protein/71060107 (2005